News Quantified

SNY – sanofi - american depositary shares (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Nurix Therapeutics, Inc. (NRIX) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript [Seeking Alpha]

Adagene Looks Attractive With ADG126 And Validating Partnerships [Seeking Alpha]

Lilly's Foundayo lowers heart attack, stroke risk in study [USA TODAY]

Juvisé Pharmaceuticals Formally Approved the Appointments of Frédéric Mascha as Executive Chairman and Chairman of the Supervisory Committee and the Nomination of Renaud Sermondade as the Group's New CEO [Yahoo! Finance]

New Research Highlights Cas-CLOVER Gene Editing Potential for CHO Cell Line Development

Sanford C. Bernstein

Bank of America Corporation

Form 6-K Sanofi For: Apr 15

Form SCHEDULE 13G/A Sanofi Filed by: Amundi

Form 6-K Sanofi For: Mar 31

Form 6-K Sanofi For: Mar 24

Form 6-K Sanofi For: Mar 10

Top News Gainers

3/16 Sanofi, Regeneron begin testing arthritis drug as coronavirus treatment [Reuters (UK)] 8.5%

3/13 Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency Use [Canadian Business Journal (Canada)] 8.2%

12/9 Sanofi ends research in diabetes, narrows units to spur profits [Reuters] 7.0%

3/17 Sanofi SA (NYSE: SNY) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. 6.5%

4/24 Sanofi confirms targets, strong demand for pain killers lifts first quarter [CNBC] 6.1%

6/6 Runners-Up From Our Sixth Annual Student Editorial Contest [The New York Times] 6.0%

3/3 FDA Approves Sanofi's Multiple Myeloma Drug [The Motley Fool] 5.9%

2/28 UPDATE 1-Sanofi to pay $11.9 mln to resolve U.S. drug charity kickback probe [Reuters] 5.4%

2/6 Sanofi delivers strong 2019 business EPS growth of 6.8% at CER 4.2%

4/13 Reasons for hope: the drugs, tests and tactics that may conquer coronavirus [Reuters] 3.6%

Top News Decliners

3/17 Here are some of the existing drugs that may be repurposed to treat coronavirus [MSNBC.com] -7.7%

3/6 Algernon Announces Availability of its NP-120 Ifenprodil Drug for Compassionate Use for Coronavirus [Canadian Business Journal (Canada)] -6.6%

3/16 Regeneron Is A Phenomenal Growth Story; Buying The Current Dip Could Be A Wise Move [Seeking Alpha] -6.5%

4/14 GlaxoSmithKline CEO calls coronavirus vaccine partnership with Sanofi 'unprecedented collaboration' [CNBC] -4.8%

4/29 GlaxoSmithKline plc (GSK) Q1 2020 Earnings Call Transcript [The Motley Fool] -4.5%

10/31 Sanofi Q3 well on track -4.0%

1/30 Human Insulin Is Available For As Little As $24.88 - But It’s Not For Everyone [Forbes] -3.4%

4/6 Sanofi upsizes debt offerings to €4B; shares up 2% [Seeking Alpha] -3.3%

3/2 Sanofi Pasteur researcher warns against overconfidence with coronavirus vaccine development [CNBC] -3.1%

3/5 Form IRANNOTICE Sanofi -3.0%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day